Abstract
<h3>To the Editor.</h3> —Apolipoprotein B (apo B) is the principal protein component of the atherogenic lipoproteins low-density (LDL) and very-low-density (VLDL). The factors that regulate plasma apo B levels are of particular interest since in some data apo B is more closely related to coronary heart disease than LDL or VLDL cholesterol.<sup>1</sup>We wondered whether insulin-like growth factor I (IGF-I) might be such a factor since the infusion of recombinant IGF-I recently was reported to lower plasma cholesterol levels.<sup>2-4</sup>Indeed, previous work had shown that IGF-I deficiency states were accompanied by hypercholesterolemia.<sup>5-7</sup>Our hypothesis was that apo B—containing lipoproteins were inversely related to circulating IGF-I in normal subjects. Insulin-like growth factor I,<sup>8</sup>insulin-like growth factor II (IGF-II),<sup>9</sup>and apo B<sup>10</sup>were measured in serum frozen at —70° obtained from 148 well-characterized, healthy men and women between the ages of 60 and 70 years for
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.